ID
17232
Beschreibung
Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00379119
Link
https://clinicaltrials.gov/show/NCT00379119
Stichworte
Versionen (1)
- 01.09.16 01.09.16 -
Hochgeladen am
1. September 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Prostate Cancer NCT00379119
Eligibility Prostate Cancer NCT00379119
- StudyEvent: Eligibility
Beschreibung
Inclusion Criteria
Alias
- UMLS CUI-1
- C1512693
Beschreibung
androgen blockade therapy (either single-agent luteinizing hormone-releasing hormone or combined androgen blockade)
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1518041
- UMLS CUI [2]
- C3495882
Beschreibung
rising prostate-specific antigen; no objective evidence of metastatic disease
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0201544
- UMLS CUI [2]
- C0027627
Beschreibung
Radiotherapy
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1522449
Beschreibung
androgen blockade therapy
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0279492
Beschreibung
no metastatic disease by abdominal/pelvic ct scan and whole-body scan
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0027627
- UMLS CUI [1,2]
- C0203669
- UMLS CUI [2,1]
- C0027627
- UMLS CUI [2,2]
- C1641132
Beschreibung
Inclusion Criteria: Patient Characteristics
Alias
- UMLS CUI-1
- C0815172
Beschreibung
CT scan
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0040405
Beschreibung
medical condition affecting the thymus, including myasthenia gravis, lymphoma, hyperthyroidism, or cachexia
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0012634
- UMLS CUI [1,2]
- C0392760
- UMLS CUI [1,3]
- C0040113
- UMLS CUI [2]
- C0026896
- UMLS CUI [3]
- C0024299
- UMLS CUI [4]
- C0020550
- UMLS CUI [5]
- C0006625
Beschreibung
autoimmune disorders
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0004364
Beschreibung
no acute illness, including active infection
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0001314
- UMLS CUI [2]
- C0009450
Beschreibung
concurrent therapy
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0009429
Beschreibung
systemic chemotherapy
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1883256
Beschreibung
immunological therapy
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0021083
Beschreibung
antiandrogen
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0002842
Beschreibung
5-alpha reductase inhibitors, pc-spes, or estrogen-containing nutraceuticals
Datentyp
boolean
Alias
- UMLS CUI [1]
- C2936788
- UMLS CUI [2]
- C0756934
- UMLS CUI [3]
- C0014939
Beschreibung
systemic steroids
Datentyp
boolean
Alias
- UMLS CUI [1]
- C2825233
Ähnliche Modelle
Eligibility Prostate Cancer NCT00379119
- StudyEvent: Eligibility
C3495882 (UMLS CUI [2])
C0027627 (UMLS CUI [2])
C0203669 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2,1])
C1641132 (UMLS CUI [2,2])
C0392760 (UMLS CUI [1,2])
C0040113 (UMLS CUI [1,3])
C0026896 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
C0020550 (UMLS CUI [4])
C0006625 (UMLS CUI [5])
C0009450 (UMLS CUI [2])
C0756934 (UMLS CUI [2])
C0014939 (UMLS CUI [3])